The Jockey Club isn't opposed to federal regulation of medication and penalties in horse racing but it would prefer Congress not tinker with the Interstate Horse Racing Act, an organization official said July 12.
- By Ray Paulick
By Ray Paulick -- As racing's fractured regulators hold their annual meetings 3,000 miles apart, the time has come for leadership to replace politics in the regulatory arena.
The board of the National Horsemen's Benevolent and Protective Association, during its winter convention in Las Vegas, Nev., Jan. 22-24, passed two motions tied to medication issues: One calls for more representation in follow-up meetings to the Racehorse Medication Summit, while the other seeks official positions from affiliates on use of race-day therapeutic medication.
Pending resolution of final contractual matters, the Claiming Crown will make its Mid-Atlantic debut at Philadelphia Park in August or September this year, event organizers said Thursday. No date has been announced.
An information campaign paid off this year for the Claiming Crown, which lured a record 244 regular nominations, up from 177 in 2000. In addition, there were 36 "open" nominations, up from 33 last year.
The National Horsemen's Benevolent and Protective Association may attempt to form a coalition of all horsemen's groups in the country to work toward common goals, one of is which is protection of the Interstate Horseracing Act of 1978. Some horsemen believe racetracks have formed cooperatives not only to secure favorable simulcasting rates, but to undermine the federal law that requires horsemen's consent when signals are transmitted.
Most Popular Stories
- Tranquility Farm Downsizing, Moving North
- That Handicapping Show: Dania Beach Stakes
- Woobine Has Per-Card Wagering Rise in 2013
- Canterbury Releases 2014 Stakes Schedule
- Bill Presented to Expand KTDF Availability
- American Gaming Association Adds Churchill
- And They're Off: 2013 Offy Awards
- Finger Lakes Launches ADW Site
- Flashback Likely Pick Among Malibu Probables
- Digging Deeper into Breeders' Cup Lasix Study